Skip to main content
Premium Trial:

Request an Annual Quote

Compendia and Ingenuity Integrate Tools for Cancer Biomarker Research

NEW YORK (GenomeWeb News) — Compendia Bioscience and Ingenuity Systems have integrated their data and pathway-analysis tools for use in cancer research, Compendia said today.
 
Compendia’s Oncomine Professional is a store of transcriptome profiles with analysis functions and a web application for data mining and visualization.
 
Ingenuity’s Pathways Analysis software allows researchers to find “mechanisms, pathways and functions” of data sets or genes, Compendia said.
 
The company said the integrated products will enable researchers to discover and validate biomarkers for cancer.
 
Financial terms of the agreement were not released.

Filed under

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.